Pharming Group NV (PHAR)

Amsterdam


Symbol		Exchange		Currency
PHAR	·	Amsterdam	·	EUR	Real-time
PHAR	·	NASDAQ	·	USD	Real-time
PHGN	·	Frankfurt	·	EUR	Delayed
PHARMa	·	BATS Europe	·	EUR	Delayed

Currency in EUR

PHAR Pro Research

0.960

+0.014(+1.48%)

Closed·07/08

Fair Value

Unlock Value

Day's Range

0.952

0.975

52 wk Range

0.834

1.818

PHAR Income Statement

Assess the Pharming Group income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the PHAR net worth.

Period Ending:

2016

31/12

2017

31/12

2018

31/12

2020

01/01

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

198.87

205.62

245.32

297.2

376.13

Total Revenues Growth

aa.aa

-6.27%

+3.39%

+19.3%

+21.15%

+26.56%

Cost Of Revenues

aa.aa

21.14

17.56

25.21

35.4

45.5

Gross Profit

aa.aa

177.73

188.06

220.1

261.8

330.63

Gross Profit Growth

aa.aa

-5.78%

+5.81%

+17.04%

+18.94%

+26.29%

Gross Profit Margin %

aa.aa

89.37%

91.46%

89.72%

88.09%

87.9%

Other Operating Expenses, Total

aa.aa

153.73

177.69

241.85

265.4

297.88

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+36.8%	+15.59%	+36.11%	+9.73%	+12.24%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	65.38	52.53	68.66	83.15	98.17
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	90.97	127.44	175.26	184.43	202.36
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-2.62	-2.28	-2.07	-2.18	-2.65

Operating Income

aa.aa

10.37

-21.75

-3.59

32.76

Operating Income Growth

aa.aa

-68.53%

-56.8%

-309.8%

+83.48%

+1,011.41%

EBIT Margin %

aa.aa

12.07%

5.04%

-8.87%

-1.21%

8.71%

Net Interest Expenses

aa.aa

-6.04

-5.27

-2.3

-3.88

-8.54

Net Interest Expenses Growth

aa.aa

-15.47%

+12.67%

+56.36%

-68.58%

-120.24%

Interest Expense, Total

aa.aa

-6.09

-5.36

-5.96

-8.74

-10.72

Interest And Investment Income

aa.aa

0.05

0.09

3.66

4.86

2.18

Other Non Operating Expenses, Total

aa.aa

15.44

2.03

-4.32

4.01

-4.45

EBT, Excl. Unusual Items

aa.aa

33.4

7.12

-28.38

-3.47

19.76

Gain (Loss) On Sale Of Assets

aa.aa

21.28

Other Unusual Items, Total

aa.aa

-10.44

-4.38

-4.92

-5.03

3.39

EBT, Incl. Unusual Items

aa.aa

23.08

14.99

-12.01

-8.49

12.85

EBT, Incl. Unusual Items Growth

aa.aa

-47.66%

-35.06%

-180.15%

+29.3%

+251.3%

EBT, Incl. Unusual Items Margin

aa.aa

11.6%

7.29%

-4.9%

-2.86%

3.42%

Income Tax Expense

aa.aa

7.08

1.31

-1.46

3.35

10.31

Net Income to Company

aa.aa

13.67

-10.55

-11.84

2.54

Minority Interest

aa.aa

0.31

Net Income

aa.aa

13.67

-10.55

-11.84

2.85

Net Income Growth

aa.aa

-57.62%

-14.52%

-177.14%

-12.26%

+124.08%

Net Income Margin %

aa.aa

8.04%

6.65%

-4.3%

-3.98%

0.76%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

13.67

-10.55

-11.84

2.85

Basic EPS - Continuing Operations

aa.aa

0.02

-0.02

Basic EPS - Continuing Operations Growth

aa.aa

-58%

-15.4%

-176.16%

-9.86%

+123.47%

Diluted EPS - Continuing Operations

aa.aa

0.02

-0.02

Diluted EPS - Continuing Operations Growth

aa.aa

-58.18%

-17.39%

-184.49%

-12.12%

+122.22%

Basic Weighted Average Shares Outstanding

aa.aa

642.01

648.68

657.02

671.35

688.77

Diluted Weighted Average Shares Outstanding

aa.aa

701.15

707.14

657.02

671.35

746.87

Dividend Per Share

aa.aa

Dividend Per Share Growth

aa.aa

EBITDA

aa.aa

30.39

17.13

-15.29

3.22

39.62

EBITDA Growth

aa.aa

-63.18%

-43.63%

-189.25%

+121.08%

+1,129.13%

EBITDA Margin %

aa.aa

15.28%

8.33%

-6.23%

1.08%

10.53%

EBIT

aa.aa

10.37

-21.75

-3.59

32.76

* In Millions of USD (except for per share items)

FAQ

What was Pharming Group’s revenue at year end?

At the end of the last reported fiscal year, Pharming Group (PHAR) recorded total revenue of 376.134 million USD.

How much revenue did Pharming Group report in the most recent quarter?

In its most recent quarterly earnings report, Pharming Group posted revenue of 90.213 million USD.

What was Pharming Group’s net income for the year?

For the full year, Pharming Group reported net income of 2.851 million USD.

How much net income did Pharming Group post in the last quarter?

In the most recent quarter, Pharming Group (PHAR) posted net income of 1.638 million USD.

What was Pharming Group’s gross profit for the year?

Gross profit for the year was reported at 330.634 million USD.

How much gross profit did Pharming Group generate last quarter?

Pharming Group recorded gross profit of 75.668 million USD in its latest quarterly report.

What was Pharming Group’s annual operating income?

For the full year, Pharming Group (PHAR) reported operating income of 32.756 million USD.

What was Pharming Group’s operating income last quarter?

Quarterly operating income was 1.313 million USD.

What was Pharming Group’s quarterly EBITDA?

In the latest quarter, EBITDA was reported at 2.673 million USD.

What was the quarter-over-quarter change in EBITDA for Pharming Group?

EBITDA changed by 248.914% million USD compared to the last quarter.

What is Pharming Group’s most recent gross profit margin?

The latest reported gross profit margin for Pharming Group (PHAR) is 83.877% million USD.

What is Pharming Group’s most recent net income margin?

Net income margin based on recent financials is 1.816% million USD.

What is Pharming Group’s most recent EBIT margin?

Pharming Group reported an EBIT margin of 1.455% million USD based on current figures.

How did Pharming Group’s revenue change compared to the previous quarter?

Revenue changed by 24.523% million USD compared to the prior quarter.

What was the quarter-over-quarter change in gross profit for Pharming Group?

In the latest quarter, gross profit changed by 14.992% million USD from the previous quarter.

S&P/TSX

36,381.23

+244.92

+0.68%

S&P/TSX 60

2,139.10

+7.23

+0.34%

US 30

54,015.90

+130.7

+0.24%

US 500

7,753.40

+43.4

+0.56%

S&P 500 VIX

14.90

-0.25

-1.65%

DAX

26,319.45

+179.32

+0.69%

Dollar Index

99.48

-0.330

-0.33%

Market Movers

Name	Last	Chg. %	Vol.
Enbridge	71.55	-1.17%	13.15M
RBC	294.59	-0.66%	2.65M
Bank of Montreal	253.24	-0.09%	2.59M
Shopify Inc	211.37	+2.40%	3.06M
Toronto Dominion Bank	169.30	-0.39%	3.79M
Suncor Energy	83.83	-2.57%	7.05M
Barrick Mining	60.96	+4.96%	8.30M

Name	Last	Chg. %	Vol.
1933 Industries	0.01	+200.00%	692.50K
FuelPositive	0.070	+133.33%	2.26M
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
James Bay Resources Ltd	0.020	+100.00%	1.47K
Digicann Ventures	0.010	+100.00%	2.00K
ePlay Digital	0.010	+100.00%	7.00K
1933 Industries	0.0100	+100.00%	692.50K

Name	Last	Chg. %	Vol.
Beckett’s	0.01	-100.00%	10.15K
Big Bear Gold	0.07	-78.33%	15.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
Albert Labs International	0.005	-50.00%	1.00K
Champion Electric	0.005	-50.00%	39.00K
International Iconic Gold Exploration	0.0050	-50.00%	276.00K
Red Lake Gold	0.0050	-50.00%	51.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	443.51	+0.19%	541.78K
TELUS	13.53	-1.60%	8.51M
Bank of Montreal	253.24	-0.09%	2.59M
Equinox Gold	16.16	+7.16%	7.24M
Alamos Gold	46.26	+6.00%	1.28M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaa Aaaaa Aaaaa	2.860	+58.57%	4.535
Aaa A	34.74	+56.97%	54.53
Aaa A Aaaa	104.38	+51.98%	158.64
Aaaaaaaaa	8.70	+48.61%	12.93
Aaa Aaaaaaaaaaaaa	5.31	+47.28%	7.82
Aaaaa Aa Aaaaa	142.78	+46.84%	209.66
Aa Aaaa A	0.47	+45.43%	0.68

Name	Last	Upside	Fair Value
Aaa Aaaaa Aaaaa	2.860	+58.57%	4.535
Aaa A	34.74	+56.97%	54.53
Aaa A Aaaa	104.38	+51.98%	158.64
Aaaaaaaaa	8.70	+48.61%	12.93
Aaa Aaaaaaaaaaaaa	5.31	+47.28%	7.82
Aaaaa Aa Aaaaa	142.78	+46.84%	209.66
Aa Aaaa A	0.47	+45.43%	0.68

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Pharming Group NV (PHAR)

PHAR Income Statement

FAQ

What was Pharming Group’s revenue at year end?

How much revenue did Pharming Group report in the most recent quarter?

What was Pharming Group’s net income for the year?

How much net income did Pharming Group post in the last quarter?

What was Pharming Group’s gross profit for the year?

How much gross profit did Pharming Group generate last quarter?

What was Pharming Group’s annual operating income?

What was Pharming Group’s operating income last quarter?

What was Pharming Group’s quarterly EBITDA?

What was the quarter-over-quarter change in EBITDA for Pharming Group?

What is Pharming Group’s most recent gross profit margin?

What is Pharming Group’s most recent net income margin?

What is Pharming Group’s most recent EBIT margin?

How did Pharming Group’s revenue change compared to the previous quarter?

What was the quarter-over-quarter change in gross profit for Pharming Group?

Trending Stocks